Denali Therapeutics DNLI
NASDAQ DNLI
$19.73 -0.12 (-0.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Denali Therapeutics (DNLI) Gross Profit (2026)

Updated

Denali Therapeutics' Gross Profit came in at $17.59 million for Q3 2026, up 400.9% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Gross Profit (2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Denali Therapeutics reported Gross Profit of $21.1 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Denali Therapeutics 3.18 Bn 98.89 Mn 17.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17.59 Mn
Jun 30, 2026 3.51 Mn
API Access

Denali Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=DNLI&period=max&api_key=YOUR_API_KEY